HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weiwei Li Selected Research

Fibrosis (Cirrhosis)

1/2021Sodium Acetate Inhibit TGF-β1-Induced Activation of Hepatic Stellate Cells by Restoring AMPK or c-Jun Signaling.
3/2014Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of extracellular matrix molecules in cultured human renal proximal tubular cells.
11/2011Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats.
4/2005Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weiwei Li Research Topics

Disease

63Neoplasms (Cancer)
08/2022 - 01/2004
23Inflammation (Inflammations)
02/2022 - 04/2015
17Breast Neoplasms (Breast Cancer)
01/2021 - 08/2004
12Infections
10/2022 - 01/2014
10COVID-19
03/2022 - 01/2020
9Neoplasm Metastasis (Metastasis)
01/2022 - 12/2013
9Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 09/2012
7Reperfusion Injury
07/2022 - 12/2009
6Alzheimer Disease (Alzheimer's Disease)
01/2022 - 08/2003
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2012
6Carcinoma (Carcinomatosis)
01/2021 - 09/2007
5Bacterial Infections (Bacterial Infection)
01/2022 - 10/2019
5Down Syndrome (Down's Syndrome)
01/2022 - 11/2019
5Wounds and Injuries (Trauma)
12/2021 - 02/2006
5Carcinogenesis
12/2021 - 08/2004
5Spinal Tuberculosis (Pott's Disease)
02/2021 - 09/2018
5Balkan Nephropathy (Balkan Endemic Nephropathy)
10/2018 - 10/2015
4Psoriasis (Pustulosis Palmaris et Plantaris)
02/2022 - 01/2019
4Hypoxia (Hypoxemia)
11/2021 - 07/2019
4Ischemia
09/2021 - 12/2009
4Type 2 Diabetes Mellitus (MODY)
05/2021 - 01/2019
4Fibrosis (Cirrhosis)
01/2021 - 04/2005
4Hypertrophy
06/2020 - 04/2005
4Osteoarthritis
12/2019 - 02/2016
4Necrosis
01/2019 - 11/2009
4Dermatitis
01/2019 - 06/2015
4Nasopharyngeal Carcinoma
01/2019 - 01/2017
4Body Weight (Weight, Body)
01/2019 - 05/2017
3Tuberculosis (Tuberculoses)
12/2022 - 12/2017
3Ovarian Neoplasms (Ovarian Cancer)
08/2022 - 08/2015
3Ischemic Stroke
07/2022 - 01/2017
3Adenocarcinoma
05/2022 - 11/2019
3Dehydration (Water Stress)
01/2022 - 09/2005
3Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2020
3Male Infertility (Male Sterility)
12/2021 - 10/2015
3Pneumonia (Pneumonitis)
11/2021 - 11/2020
3Infarction (Infarctions)
09/2021 - 12/2009
3Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2021 - 10/2014
3Lung Neoplasms (Lung Cancer)
01/2021 - 11/2019
3Atherosclerosis
01/2021 - 07/2002
3Diabetes Mellitus
01/2021 - 01/2019
3Colonic Neoplasms (Colon Cancer)
01/2020 - 08/2015
3Starvation
01/2020 - 02/2015

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
10/2022 - 02/2006
12Pharmaceutical PreparationsIBA
05/2022 - 08/2006
9MicroRNAs (MicroRNA)IBA
08/2022 - 09/2012
9Therapeutic UsesIBA
12/2021 - 11/2011
8Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2014
8Peptides (Polypeptides)IBA
01/2020 - 08/2003
7CateninsIBA
12/2021 - 10/2012
6Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2010
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 11/2011
5Glucose (Dextrose)FDA LinkGeneric
07/2022 - 03/2014
5Messenger RNA (mRNA)IBA
01/2022 - 08/2013
5Cell Adhesion MoleculesIBA
01/2022 - 11/2019
5DNA (Deoxyribonucleic Acid)IBA
12/2020 - 01/2017
5GhrelinIBA
01/2020 - 11/2017
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2019 - 10/2016
5CytokinesIBA
01/2018 - 03/2011
4LipopolysaccharidesIBA
11/2022 - 09/2011
4VaccinesIBA
10/2022 - 10/2009
4AntigensIBA
10/2022 - 09/2012
4InflammasomesIBA
06/2022 - 01/2019
4AntioxidantsIBA
02/2022 - 04/2017
4NF-kappa B (NF-kB)IBA
02/2022 - 06/2015
4Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 01/2019
4Interleukin-6 (Interleukin 6)IBA
02/2022 - 10/2016
4LipidsIBA
01/2022 - 09/2013
4Indicators and Reagents (Reagents)IBA
01/2021 - 07/2012
4Tyrosine Kinase InhibitorsIBA
01/2021 - 11/2019
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 11/2019
4RNA (Ribonucleic Acid)IBA
01/2021 - 01/2018
4Long Noncoding RNAIBA
01/2021 - 01/2020
4Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 11/2006
4Ribose (D-Ribose)IBA
01/2019 - 08/2018
4OxazoloneIBA
01/2019 - 06/2015
4Aristolochic AcidsIBA
10/2018 - 01/2016
4Progesterone Receptors (Progesterone Receptor)IBA
12/2013 - 08/2004
3C-Reactive ProteinIBA
12/2022 - 02/2015
3Neuroprotective AgentsIBA
07/2022 - 01/2017
3Imiquimod (Aldara)FDA LinkGeneric
02/2022 - 01/2019
3AntibodiesIBA
01/2022 - 01/2020
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2019
3Biological ProductsIBA
11/2021 - 08/2018
3PAR-2 ReceptorIBA
10/2021 - 10/2015
3Bevacizumab (Avastin)FDA Link
07/2021 - 10/2020
3Antiviral Agents (Antivirals)IBA
01/2021 - 01/2016
3Blood Glucose (Blood Sugar)IBA
12/2020 - 05/2017
3Cisplatin (Platino)FDA LinkGeneric
11/2020 - 01/2017
3Phosphotransferases (Kinase)IBA
01/2020 - 03/2011
3ParaffinIBA
01/2020 - 04/2014
3EnzymesIBA
01/2020 - 01/2004

Therapy/Procedure

16Therapeutics
07/2022 - 06/2008
9Debridement
12/2022 - 12/2017
8Drug Therapy (Chemotherapy)
07/2022 - 08/2012
4Bone Transplantation (Bone Grafting)
03/2020 - 12/2017
4Radiotherapy
01/2019 - 08/2012
3Chemoradiotherapy
01/2022 - 11/2018
3Length of Stay
11/2021 - 09/2018
3Immunotherapy
07/2020 - 03/2014